News | April 2023

dQ&A® Research on Use of High Doses of Basal Insulin Published in Clinical Diabetes

The dQ&A team recently worked in conjunction with Sanofi US to publish results from a study on high doses of basal insulin in Clinical Diabetes.

Read the full publication here: Survey Reveals Patient and Health Care Provider Experiences and Challenges With the Use of High Doses of Basal Insulin

Please join us in congratulating dQ&A team members Christianne Pang, Jacqueline Tait, Alice Morgan, and Richard Wood on their contribution to this important research!

About dQ&A – The Diabetes Research Company

dQ&A is a social enterprise committed to making life better for people with diabetes. We harness patient voices to drive better business results and better health outcomes. For over 14 years, we have been comprehensively tracking the diabetes experience in the United States, Canada, and Europe. We are trusted by diabetes industry leaders for our independence, commitment, and expertise. Our team has decades of experience in quantitative and qualitative research with a deep knowledge of diabetes. We’re efficient and effective; our insights are actionable and accessible. To learn more, send us an email at For research highlights, visit us at and follow us on LinkedIn (dQ&A – The Diabetes Research Company)